Skyrizi

AbbVie’s Skyrizi hits the spot in refractory psoriasis
Pharmaphorum
Mon, 03/20/23 - 11:21 am
AbbVie
Skyrizi
psoriasis
Top 10 Pharma TV Ad Spenders in 2022 — Anti-Inflammatories and Diabetes Drugs Dominate
Xtalks
Sun, 01/29/23 - 01:31 pm
television ads
pharma marketing
DTC ads
AbbVie
Rinvoq
Dupixent
Sanofi
Regeneron
Skyrizi
Novo Nordisk
Ozempic
Jardiance
Eli Lilly
Boehringer Ingelheim
Rybelsus
Trulicity
Rexulti
Otsuka
Lundbeck
Tremfya
JNJ
Verzenio
Looking past Humira, AbbVie boosts sales forecasts for successor drugs
BioPharma Dive
Wed, 01/11/23 - 12:22 pm
JPMHC 2023
AbbVie
Richard Gonzalez
Pharma CEOs
Humira
Skyrizi
Rinvoq
BMS' Zeposia and AbbVie's Skyrizi Shake Up First-Line Prescribing Patterns in the US Ulcerative Colitis and Crohn's Disease Markets, Spherix Reports
PR Newswire
Sun, 12/4/22 - 01:24 pm
Bristol Myers Squibb
AbbVie
Zeposia
Skyrizi
ulcerative colitis
Crohn's Disease
gastroentrologists
AbbVie Drops Autoimmune Candidate, Prioritizes Skyrizi and Rinvoq
BioSpace
Tue, 11/1/22 - 11:04 am
AbbVie
cedirogant
Skyrizi
Rinvoq
Humira
Where Will AbbVie Be in 3 Years?
Motley Fool
Fri, 09/30/22 - 10:50 am
AbbVie
Humira
biosimilars
Rinvoq
Skyrizi
Vraylar
Pushing for top spot in Big Pharma, AbbVie lands a key approval for its blockbuster Skyrizi
Endpoints
Mon, 06/20/22 - 10:33 am
AbbVie
Skyrizi
FDA
Crohn’s disease
Janssen Presents New Data that could Set Anti-Inflammatory Drug Apart
BioSpace
Thu, 05/19/22 - 09:00 pm
JNJ
Janssen
Tremfya
Skyrizi
AbbVie
anti-inflammatories
AbbVie Snags FDA Approval for Another Indication. Will It Become Another Blockbuster?
Motley Fool
Fri, 02/18/22 - 10:30 am
AbbVie
Skyrizi
FDA
psoriatic arthritis
AbbVie's Gonzalez: Skyrizi and Rinvoq to become Humira 2.0 — while adding an indication for atopic dermatitis
Endpoints
Wed, 02/2/22 - 11:46 pm
AbbVie
earnings
Rick Gonzalez
Skyrizi
Rinvoq
AbbVie's (ABBV) Skyrizi Gets FDA Nod for Psoriatic Arthritis
Yahoo/Zacks.com
Mon, 01/24/22 - 11:30 pm
AbbVie
Skyrizi
FDA
psoriatic arthritis
JPM 2022: AbbVie adjusts 2025 individual sales projections for Rinvoq and Skyrizi but not their combined total of $15B
Fierce Pharma
Thu, 01/13/22 - 11:00 am
AbbVie
Rinvoq
Skyrizi
JPMHC 2022
What AbbVie's Recent Drug News Means for Shareholders
Motley Fool
Tue, 12/28/21 - 10:57 am
AbbVie
Skyrizi
Crohn’s disease
Europe
AbbVie seeks EMA approval for risankizumab (Skyrizi) to treat moderate to severe Crohn’s disease
Pharmaceutical Business Review
Wed, 12/1/21 - 10:22 am
AbbVie
Europe
EMA
Skyrizi
Crohn’s disease
AbbVie's post-Humira stalwarts Skyrizi, Rinvoq performing exactly as hoped, CEO says
Fierce Pharma
Sat, 07/31/21 - 10:07 pm
AbbVie
earnings
Humira
Skyrizi
Rinvoq
J&J touts Tremfya win in Humira-resistant psoriatic arthritis patients amid showdown with AbbVie's Skyrizi
Fierce Pharma
Thu, 06/3/21 - 10:51 pm
JNJ
Tremfya
psoriatic arthritis
AbbVie
Skyrizi
AbbVie's Skyrizi takes home a win in late-stage Crohn's study, adding some heft to its expansion plans
Endpoints
Wed, 06/2/21 - 10:55 am
AbbVie
Skyrizi
clinical trials
Crohn’s disease
AbbVie, building out its post-Humira future, posts 5 late-stage trial wins for Skyrizi and Rinvoq
Fierce Pharma
Wed, 05/26/21 - 12:05 pm
AbbVie
Humira
drug pricing
patents
immunology
Skyrizi
Rinvoq
clinical trials
Crohn's Disease
atopic dermatitis
AbbVie presents applications to FDA and EMA for approval of SKYRIZI in psoriatic arthritis
Pharmaceutical Business Review
Thu, 04/8/21 - 10:22 am
AbbVie
Skyrizi
FDA
EMA
psoriatic arthritis
AbbVie's immunology newbies Skyrizi and Rinvoq pick up the slack from declining Humira, but safety questions dog execs
Fierce Pharma
Wed, 02/3/21 - 11:22 pm
AbbVie
FDA
Skyrizi
Rinvoq
Humira
earnings

Pages